Sputnik V shot achieved 91.6% efficacy against coronavirus symptoms, says paper in U.K.’s Lancet MOSCOW—Russia’s homegrown Sputnik V vaccine showed high levels of efficacy and safety in a peer-reviewed study released Tuesday, a potential boost for the Kremlin’s aim to promote the Covid-19 shot abroad and curb the pandemic at home. The findings, from a preliminary analysis...